Transaction in Own Shares

Jupiter Fund Management PLC
14 March 2025
 

14 March 2025

Jupiter Fund Management plc

(the "Company" or "Jupiter")

 

Transaction in own shares

 

Jupiter announces that on 14 March 2025 it has purchased, in accordance with the authority granted by shareholders at the 2024 Annual General Meeting of the Company, the following number of its ordinary shares of 2 pence each on the London Stock Exchange through Numis Securities Limited as part of its share buyback programme announced on 27 February 2025.

 

Date of purchase:

14 March 2025

 

Number of ordinary shares purchased:

80,564

 

Highest price per share:

£0.758

 

Lowest price per share:

£0.742

 

Weighted average price per share:

£0.750470

 

The Company intends to hold the purchased shares in Treasury.  Following this transaction the Company holds 2,109,045 shares in Treasury and has 542,870,465 shares in issue excluding Treasury shares.  Therefore, the total voting rights in the Company is 542,870,465.  This figure may be used by shareholders as the denominator for the calculation by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

All transactions under this programme will be published on the Company's website (www.jupiteram.com) on a weekly basis.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), a full breakdown of the individual purchases is attached to this announcement.



http://www.rns-pdf.londonstockexchange.com/rns/8221A_1-2025-3-14.pdf

 


 

Notes:

LEI Number: 5493003DJ1G01IMQ7S28

For further information please contact:

 


Investors

Media

Jupiter

Helen Archbold

+44 (0)20 3817 1609

Victoria Howley

+44 (0)20 3817 1657

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100